Expanded indication for LevemirNovo Nordisk's Levemir is now indicated for the treatment of type 2 diabetes in combination with oral antidiabetic agents in adults who are not satisfactorily controlled on oral antidiabetic agents alone. CACDS forum explores global innovation in pharmacyPharmacy heavyweights from across Canada came together in Toronto on Tuesday, November 4th for the Canadian Association of Chain Drug Stores' Global Innovation in Pharmacy conference. Erbitux for advanced colorectal cancer Bristol-Myers Squibb is introducing Erbitux, a recombinant monoclonal antibody used for colorectal and head/neck cancers. Clincal in Brief - Nov 4 2008 SONIC gives boost to infliximab for Crohn’s Corticosteroid-free remission doubled in patients taking infliximab combo compared with azathioprine alone Alzheimer’s drug targeting beta amyloid fails in phase III trial Enzymes offer promise as targets for treating progressive MS New drugs available to replace discontinued restless leg treatment Weight-loss surgery linked to bone loss Vigilance for nutritional deficiencies before and after bariatric surgery is crucial Angeliq: continuous therapy for menopausal symptoms Bayer is introducing Angeliq (drospirenone 1 mg and estradiol-17 First Previous 1264 1265 1266 1267 1268 Next Last
